NOTRELOAD AI
  • NOTRELOAD AI
  • Stocks BUZZ.
  • XYZ.
  • XY.
  • #TrumpTrade
  • Invest ↗
Sign in Subscribe

Perrigo Rethinks Its Baby Formula Business

Perrigo reviews its store-brand baby formula business due to quality issues. It is shifting focus to higher-profit health brands instead.

Perrigo Rethinks Its Baby Formula Business
Credit: "Firefly" Perrigo
Already have an account? Sign in.
11/05/2025 · 11:59 AM
PRGO
/ Read more

Feed↓

Axon Shares Plunge After Missing Q3 Profit Estimates Amid Tariff Pressures
11/05/2025 · 12:43 PM

Axon Shares Plunge After Missing Q3 Profit Estimates Amid Tariff Pressures

Axon Enterprise shares drop 10% after missing profit estimates due to rising tariff costs. The Taser-maker raises 2025 revenue outlook and announces a $625M Carbyne acquisition.

/ Subscriber only
FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation
11/05/2025 · 11:40 AM

FDA Greenlights Linaclotide (Linzess) for Children 7 Years and Older with Irritable Bowel Syndrome with Constipation

Ironwood's Linzess is the first FDA-approved drug for children 7+ with IBS-C (chronic constipation, pain, and bloating).

/ Subscriber only
Orexin Drug Race: Centessa Shows Promise, Alkermes Stands Strong
Featured/ 11/05/2025 · 10:28 AM

Orexin Drug Race: Centessa Shows Promise, Alkermes Stands Strong

Centessa has great sleep drug data, easing daytime sleepiness. Alkermes stock jumped 7% as its competing drug is still strong.

/ Subscriber only
  • UP↑
  • Terms/Privacy
  • Sign up
  • Sign in
  • Discord
  • X
  • Bluesky
  • Telegram
  • Reach out →
  • Invest ↗
  • NOTRELOAD AI
DON'T FALL BEHIND. ©2025
Email address Subscribe